外侧肘肌腱病核心结局指标集(COS-LET)开发方案
外侧肘肌腱病(LET)研究结局指标高度异质,限制证据合成。本研究拟采用三阶段方法开发LET核心结局指标集(COS):系统综述汇总现有测量工具,映射至国际肌腱病共识(ICON)九大核心域形成候选工具,再经国际三阶段Delphi研究以70%共识阈值筛选。目前尚无LET的COS,本方案产出将为未来英文研究提供最低推荐COS。
要点
- LET研究结局指标异质,需统一COS以利证据合成。
- 三阶段法:系统综述、工具映射ICON九域、国际Delphi共识。
- Delphi采用OMERACT真值、可行性、区分度筛选,共识阈值70%。
核心结论
- 目前尚无用于LET试验或临床实践测量的COS。
- 本项目将产出推荐用于未来所有英文LET研究的最低COS。
研究设计与样本
- 本研究为COS开发方案,采用三阶段方法。
- 第一阶段为系统综述,汇总研究LET的文献中使用的所有测量工具。
- 第二阶段由对LET有特殊兴趣的临床医生和研究人员组成指导委员会,将工具映射至九个肌腱病核心结局域,形成候选工具集。
- 第三阶段为国际三阶段Delphi研究,纳入有经验的临床医生、研究人员和患者。
主要发现
- 原文未报告本研究结果(此为方案)。
- 背景指出2019年ICON工作组已发布共识,定义肌腱病研究应测量的九个核心域。
关键数值与推荐
- Delphi研究中候选工具基于OMERACT真值、可行性和区分度过滤器筛选。
- 共识阈值设定为70%一致。
临床怎么用
- 未来英文LET研究应使用本项目产出的最低COS进行结局评估。
- COS将作为LET结局评价的模板。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lateral elbow tendinopathy (LET) is a common condition that can cause significant disability and associated socioeconomic cost. Although it has been widely researched, outcome measures are highly variable which restricts evidence synthesis across studies. In 2019, a working group of international experts, health care professionals and patients, in the field of tendinopathy (International Scientific Tendinopathy Symposium Consensus (ICON) Group), published the results of a consensus exercise defining the nine core domains that should be measured in tendinopathy research. The aim of this study is to develop a core outcome set (COS) for LET mapping to these core domains. The primary output will provide a template for future outcome evaluation of LET. In this protocol, we detail the methodological approach to the COS-LET development. METHODS: This study will employ a three-phase approach. (1) A systematic review of studies investigating LET will produce a comprehensive list of all instruments currently employed to quantify the treatment effect or outcome. (2) Instruments will be matched to the list of nine core tendinopathy outcome domains by a Steering Committee of clinicians and researchers with a specialist interest in LET resulting in a set of candidate instruments. (3) An international three-stage Delphi study will be conducted involving experienced clinicians, researchers and patients. Within this Delphi study, candidate instruments will be selected based upon screening using the Outcome Measures in Rheumatology (OMERACT) truth, feasibility and discrimination filters with a threshold of 70% agreement set for consensus. CONCLUSIONS: There is currently no COS for the measurement or monitoring of LET in trials or clinical practice. The output from this project will be a minimum COS recommended for use in all future English language studies related to LET. The findings will be published in a high-quality journal and disseminated widely using professional networks, social media and via presentation at international conferences. TRIAL REGISTRATION: Registered with the Core Outcome Measures in Effectiveness Trials (COMET) database, November 2019. https://www.comet-initiative.org/Studies/Details/1497 .
引用
- Bateman M, Evans JP, Vuvan V, et al. Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET). Trials. 2021. PMID: 33971941. doi:10.1186/s13063-021-05291-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。